Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Part of paid clinical trials in New York, New York.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT00003742
- Phase
- PHASE1
- Status
- Completed
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUG
- irinotecan hydrochloride — DRUG
- paclitaxel — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients with locally advanced or metastatic solid tumors.
Key Dates
- Start date
- Oct 31, 1998
- Status verified
- Jun 2013
- Primary completion
- Aug 31, 2001
- Completion
- Aug 31, 2001
Study Design
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | - |
Find similar trials in New York, NY
By research site
Related Studies
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid TumorsRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerRecruiting · Barbara Ann Karmanos Cancer Institute · Detroit, Michigan
- Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy ParticipantsRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Registry of Older Patients With CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Boone, North Carolina